BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29050232)

  • 1. Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
    Lachen-Montes M; Zelaya MV; Segura V; Fernández-Irigoyen J; Santamaría E
    Oncotarget; 2017 Sep; 8(41):69663-69679. PubMed ID: 29050232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
    Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
    Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
    Lachén-Montes M; González-Morales A; Schvartz D; Zelaya MV; Ausin K; Fernández-Irigoyen J; Sánchez JC; Santamaría E
    J Proteomics; 2019 Jun; 201():37-47. PubMed ID: 30999060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes.
    Lachén-Montes M; Íñigo-Marco I; Cartas-Cejudo P; Fernández-Irigoyen J; Santamaría E
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer's Disease.
    Lachen-Montes M; González-Morales A; Palomino M; Ausin K; Gómez-Ochoa M; Zelaya MV; Ferrer I; Pérez-Mediavilla A; Fernández-Irigoyen J; Santamaría E
    Front Aging Neurosci; 2019; 11():141. PubMed ID: 31244650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
    Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
    Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal dementia progresses to death faster than Alzheimer disease.
    Roberson ED; Hesse JH; Rose KD; Slama H; Johnson JK; Yaffe K; Forman MS; Miller CA; Trojanowski JQ; Kramer JH; Miller BL
    Neurology; 2005 Sep; 65(5):719-25. PubMed ID: 16157905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
    Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease.
    Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA
    Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.
    Barnes J; Whitwell JL; Frost C; Josephs KA; Rossor M; Fox NC
    Arch Neurol; 2006 Oct; 63(10):1434-9. PubMed ID: 17030660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited article: the Alzheimer disease-frontotemporal lobar degeneration spectrum.
    van der Zee J; Sleegers K; Van Broeckhoven C
    Neurology; 2008 Oct; 71(15):1191-7. PubMed ID: 18838666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.